⌘K
Loading ticker…
As of 2026-08-24, National Vision Holdings, Inc. Common Stock (EYE) has a 3-month relative strength percentile of 60 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 44. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.6%, relative volume 1.13×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
EYE is in a stage 4 downtrend, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -7.6% / -23.2%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
EYE appears in 1 ETF as of Jun 2026: PSC at 0.08% weight, $2M notional.
Held by 94 ETFs · $526M across latest filings · largest weight 1.54% (PEZ).
Top 1 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| PSC | 0.08% | $2M | −0.05 pp |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EYE Jan avg: 2.08% median: 4.04% win: 75% σ: 8.08% n: 4 2022-04-12 → 2026-07-31 | EYE Feb avg: 6.96% median: 6.92% win: 75% σ: 13.66% n: 4 2022-04-12 → 2026-07-31 | EYE Mar avg: -14.57% median: -4.63% win: 25% σ: 23.47% n: 4 2022-04-12 → 2026-07-31 | EYE Apr avg: -7.28% median: -10.35% win: 20% σ: 12.40% n: 5 2022-04-12 → 2026-07-31 | EYE May avg: 2.78% median: -13.38% win: 40% σ: 37.43% n: 5 2022-04-12 → 2026-07-31 | EYE Jun avg: 2.06% median: -2.27% win: 40% σ: 12.42% n: 5 2022-04-12 → 2026-07-31 | EYE Jul avg: 5.37% median: 5.96% win: 80% σ: 10.05% n: 5 2022-04-12 → 2026-07-31 | EYE Aug avg: -8.43% median: -10.39% win: 25% σ: 17.37% n: 4 2022-04-12 → 2026-07-31 (current) | EYE Sep avg: 4.29% median: 0.78% win: 50% σ: 16.51% n: 4 2022-04-12 → 2026-07-31 | EYE Oct avg: -1.74% median: -4.32% win: 25% σ: 10.72% n: 4 2022-04-12 → 2026-07-31 | EYE Nov avg: 14.09% median: 14.19% win: 100% σ: 4.26% n: 4 2022-04-12 → 2026-07-31 | EYE Dec avg: -3.79% median: -7.35% win: 25% σ: 12.17% n: 4 2022-04-12 → 2026-07-31 |